Now you can find lymphoma earlier than ever

Cancer affects many of your patients, with one in four dogs facing a diagnosis in their lifetime¹. In many cases, patients are not diagnosed until the later stages, when clinical signs are already present. Unfortunately, this delay can often lead to poorer outcomes and shorter survival rates.

Lymphoma is one of the most common cancers in dogs, comprising up to 24% of new diagnoses². As oncology continues to shift towards early detection, giving veterinary teams and families more time to plan and a wider range of treatment opportunities. Diagnosing lymphoma before it causes illness has the potential to significantly improve outcomes.

Now, earlier detection is finally within reach. IDEXX Cancer Dx™ testing is a groundbreaking diagnostic that uses innovative, proprietary technologies to accurately detect circulating biomarkers specific to canine lymphoma in at-risk dogs³.

With a simple blood test, Cancer Dx can identify lymphoma up to 6–8 months before clinical signs, giving families valuable time to consider the best next step.

Cancer Dx also fits seamlessly into your existing workflow. It can be added to routine wellness screening for senior dogs (≥7 years) and at‑risk breeds from 4 years using the same sample, or used to diagnose unwell patients when lymphoma is suspected.

Early cancer answers have never been more accessible. When added to a qualifying profile, Cancer Dx costs as little as $29*, and where available, B/T‑cell phenotype is included at no additional cost, to help guide clinical decisions with greater clarity.

And this is only the beginning. IDEXX remains committed to relentless innovation, with the Cancer Dx panel expanding to detect more than 50% of common canine cancers in the coming years.

 Discover Cancer Dx

*Correct at the time of publishing as at May 2026. IDEXX reserves the right to change prices at any time.

†At-risk dogs include all dogs ≥ 7 years old and high-risk breeds ≥ 4 years old.

References

1. What are the most common types of cancers in dogs? How many dogs typically get cancer? Veterinary Cancer Society; 2021. Accessed December 15, 2025. vetcancersociety.org/pet-owners/faqs
2. Vail DM, Pinkerton M, Young KM. Hematopoietic tumors. In: Vail DM, Thamm

DH, Liptak JM, eds. Withrow & MacEwen’s Small Animal Clinical Oncology. 6th ed.

Saunders; 2020:688–772. doi:10.1016/B978-0-323-59496-7.00033-5

3. Data on file at IDEXX Laboratories, Inc. Westbrook, Maine USA: Data based on testing performed at IDEXX Reference Laboratories in North America between November 1, 2024, and December 6, 2024. Analysis Report: IDEXX Cancer Dx Validation, 100282 [008_CancerDx-Validation-Report-2.Rmd].